Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Interactions with E/C/F/TAF (Genvoya)

Tuesday 01 December 2015

The web and app versions of the interaction charts have been updated to include Genvoya®, a single tablet regimen containing elvitegravir, cobicistat, emtricitabine (FTC) and tenofovir alafenamide. Interactions are listed under the abbreviation E/C/F/TAF and the combination is currently classified as an integrase inhibitor.
We are preparing updated records for elvitegravir/cobicistat to reflect fully its administration as a single tablet regimen with emtricitabine and tenofovir-DF (Stribild®). Once this has been completed, the printable charts will be updated with these changes.
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017
building_better_healthcare_awards_2016 healthline-best-HIV-and-AIDS-apps-of-2016